Holen Sie sich die Stockscreener-App
0.7237
4.92%
-0.0367
Schlusskurs vom Vortag:
$0.7603
Offen:
$0.75
24-Stunden-Volumen:
208.19K
Relative Volume:
0.83
Marktkapitalisierung:
$738.01K
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-82.74%
1M Leistung:
-87.56%
6M Leistung:
-98.60%
1J Leistung:
-99.15%
1-Tages-Spanne:
$0.6879
$0.75
1-Wochen-Bereich:
$0.64
$0.9122
52-Wochen-Spanne:
$0.64
$101.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
Firmenname
Psyence Biomedical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
0.722 | 777.16K | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.86 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.03 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.59 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.18 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.53 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Psyence Biomedical Ltd Aktie (PBM) Neueste Nachrichten
Psyence BioMed Announces Adjournment of Annual and Special Shareholder Meeting on January 22, 2026 - The Manila Times
Too few shareholders: Psyence BioMed postpones meeting to Feb. 12 - Stock Titan
Psyence Biomedical Calls January 22, 2026 Shareholder Meeting to Vote on Financials, Board and Share Consolidation - TipRanks
Psyence Biomedical sets Jan. 20 as effective date for reverse stock split - MSN
Psyence Biomedical postpones planned reverse stock split By Investing.com - Investing.com Nigeria
Psyence Biomedical announces postponement of reverse stock split effective date - TipRanks
Psyence Biomedical postpones planned reverse stock split - Investing.com
Psyence Biomedical Ltd. Announces Postponement of Reverse Stock Split Effective Date - Quiver Quantitative
Psyence BioMed Announces Postponement of Previously Announced Reverse Stock Split Effective Date - GlobeNewswire
Reverse stock split on hold: Psyence BioMed keeps PBM trading - Stock Titan
Why Psyence Biomedical Ltd. stock could benefit from AI revolutionConsumer Goods Stocks & Free Powerful Profit Generation - bollywoodhelpline.com
Psyence BioMed Sets January 20, 2026 Start Date for 1-for-6.25 Reverse Stock Split - TipRanks
Day Trade: Is RLAY forming a bullish divergenceJuly 2025 Snapshot & Weekly High Return Stock Forecasts - baoquankhu1.vn
Can Psyence Biomedical Ltd. outperform in the next rally2025 Volatility Report & Weekly Watchlist for Consistent Profits - bollywoodhelpline.com
Entry Recap: Will Psyence Biomedical Ltd benefit from rate cutsWeekly Loss Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Aug Technicals: Is Psyence Biomedical Ltd a top pick in the sectorJuly 2025 Reactions & Smart Money Movement Tracker - baoquankhu1.vn
Quarterly Recap: Whats the beta of Psyence Biomedical Ltd stockGap Down & Daily Technical Forecast Reports - baoquankhu1.vn
Psyence Biomedical Shares Set to Reverse Split on Tuesday, January 20th (NASDAQ:PBM) - Defense World
Breakout Move: Can LSI Industries Inc. benefit from deglobalizationPortfolio Gains Summary & Safe Capital Growth Tips - baoquankhu1.vn
Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026 - Intellectia AI
Psyence Biomedical announces 1-for-6.25 share consolidation By Investing.com - Investing.com Nigeria
1-for-6.25 split leaves Psyence BioMed with 1,022,177 shares outstanding - Stock Titan
Psyence Biomedical Ltd. Announces 1-for-6.25 Share Consolidation Effective January 20, 2026 - Quiver Quantitative
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split - Chartmill
Aug Catalysts: Can Psyence Biomedical Ltd Equity Warrant outperform in the next rally2025 Support & Resistance & Precise Swing Trade Alerts - baoquankhu1.vn
Psyence Biomedical Board Backs 2026 Strategy and Potential Share Buyback Program - TipRanks
Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Down 63.6% in December - Defense World
Psyence BioMed Approves 2026 Financial Strategy, Board Authorizes Share Buyback on Value Opportunity - The Manila Times
Why Psyence BioMed may buy its own shares while developing therapies - Stock Titan
How Psyence Biomedical Ltd. stock performs in weak economyJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Улправда
What is the fair value of Psyence Biomedical Ltd. stock nowFit and Size Notes & lightweight options for faster days - ulpravda.ru
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
Is Psyence Biomedical Ltd. stock attractive for hedge fundsWeekly Trade Report & Expert Curated Trade Setup Alerts - ulpravda.ru
Surprises Report: Will Psyence Biomedical Ltd. Equity Warrant stock gain from strong economyJuly 2025 Breakouts & Daily Price Action Insights - Улправда
Will Psyence Biomedical Ltd. stock benefit from infrastructure spendingJuly 2025 PostEarnings & Reliable Breakout Forecasts - Улправда
What valuation multiples suggest for Psyence Biomedical Ltd. Equity Warrant stockQuarterly Investment Review & Reliable Intraday Trade Alerts - ulpravda.ru
How currency fluctuations impact Psyence Biomedical Ltd. Equity Warrant stock2025 Trading Volume Trends & Low Volatility Stock Recommendations - ulpravda.ru
Can Psyence Biomedical Ltd. stock rebound after recent weaknessWeekly Trade Report & Reliable Intraday Trade Alerts - Улправда
Will Psyence Biomedical Ltd. Equity Warrant stock deliver consistent dividendsMarket Activity Recap & Weekly Breakout Watchlists - Улправда
Why Psyence Biomedical Ltd. Equity Warrant stock appeals to analystsWeekly Stock Analysis & Expert Verified Stock Movement Alerts - Улправда
How Psyence Biomedical Ltd. stock reacts to oil pricesWeekly Earnings Recap & Technical Confirmation Trade Alerts - Улправда
Psyence Biomedical Ltd.Ordinary Shares (NQ: PBM - FinancialContent
Psyence Biomedical announces milestone in natural ibogaine HCl production - TipRanks
Psyence Biomedical Ltd. Announces Board Changes - marketscreener.com
Psyence BioMed Achieves Milestone in Natural Ibogaine HCl Production and Strengthens Balance Sheet With No Debt and $12m Cash - The Manila Times
Published on: 2026-01-04 19:06:08 - earlytimes.in
Investment Recap: Why Psyence Biomedical Ltd Equity Warrant stock appeals to analystsCPI Data & Real-Time Market Sentiment Alerts - Bộ Nội Vụ
Gainers Report: Why Psyence Biomedical Ltd stock could benefit from AI revolutionSell Signal & Real-Time Chart Pattern Alerts - moha.gov.vn
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing - TMX Newsfile
Psyence Biomedical (NASDAQ:PBM) Trading Down 6.1% – Here’s Why - Defense World
Finanzdaten der Psyence Biomedical Ltd-Aktie (PBM)
Es liegen keine Finanzdaten für Psyence Biomedical Ltd (PBM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
3.19%
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):